Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

Yet, uptake levels of vaccines in the US would tell a different story. As of mid-December, only 20.9 percent of adults in the ...

Clinical-stage biotechnology company Vaxxas has appointed three global vaccine experts as advisors as it progresses its ...

The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

Netherlands-based Bilthoven Biologicals, the Dutch subsidiary of the Serum Institute of India and a leading end-to-end ...

To address this issue, we designed a seven-minute counteradvertising video informed by “inoculation theory”, which is a concept similar to vaccination. By exposing viewers to weakened forms of ...

Scientists at Stanford are developing a painless, topical vaccine using a common skin bacterium to trigger immunity.

Vaxxas, a clinical-stage biotechnology company, has announced the appointments of three globally respected vaccine experts as ...

French biotech Valneva has secured marketing approval in the UK for its chikungunya vaccine, Ixchiq (chikungunya vaccine), ...

Instead of injections, they are investigating whether a common skin bacterium, Staphylococcus epidermidis, could deliver vaccines through a simple topical cream. The discovery challenges long-held ...

Republican Sen. Bill Cassidy of Louisiana, a former physician who has spent his career touting the safety of vaccines, will ...